Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Why did General Motors lose $1.1 billion to tariffs? What is in the new US-Japan trade deal? How will Coca-Cola's cane sugar launch affect sales? Why is Jerome Powell staying as Fed Chair? What caused Kohl’s stock surge this week? How is OpenAI partnering with Oracle on data centers? What impact are tariffs having on US manufacturers?

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

abcnews.go.com/Business/wireStory/sarepta-shares-slide-drugmaker-bows-fda-pressure-pause-123958373

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators

This story appeared on abcnews.go.com, 2025-07-22 15:44:34.